On the other hand, one of the first studies reporting the tumor-suppressive effect of miR-106a in GBM demonstrated that the low expression of miR-106a in human glioma specimens is associated with the accumulation of E2F1 protein and high-grade glioma [81]. The gene discussed is E2F1; the disease is central nervous system cancer.